DiviDrip · ENTX

ENTX — Entera Bio Ltd.

ENTX is Entera Bio Ltd. (Healthcare) — a non-dividend-paying stock. Trading at $2.95. Market cap: $511M. Capital Quality Rank: 38/100 — Stagnant mediocrity.

Stock snapshot

Price$2.95
Market cap$511M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)38 / 100 · Stagnant mediocrity
ROIC (TTM)-68.3%
Revenue CAGR (3y)-32.1%
Shareholder buyback yield-18.49%
Altman Z-score zoneSafe

About ENTX

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Listed2018Employees22HQJerusalemSectorHealthcareWebsiteenterabio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ENTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ENTX's current stock price?

ENTX (Entera Bio Ltd.) is currently trading at $2.95.

Does ENTX pay a dividend?

ENTX (Entera Bio Ltd.) does not currently pay a regular dividend.

What is ENTX's Capital Quality Rank?

ENTX has a Capital Quality Rank of 38/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ENTX in DiviDrip

Add ENTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow